NAMS

NASD NewAmsterdam Pharma Company N.V.
Sep 30, 2026 · 5:57 AM ET LAST TRADE Market Closed

$23.81 ↑ +0.00 (+0.00%) Trading Up from the previous close of $23.81

YTD change
-32.13%
vs 20-day SMA
+2.35%
vs 200-day SMA
-24.04%

Price ranges

Previous day
$23.26 $24.54
open $23.52 close $23.81
+$0.29 (+1.23%)
Today
$0.00 $0.00
$23.81
Past week
$21.95 $24.54
from $23.32 now $23.81
+$0.49 (+2.10%)
Past month
$21.02 $26.19
from $25.34 now $23.81
-$1.53 (-6.04%)
This year
$21.02 $42.21
from $35.08 now $23.81
-$11.27 (-32.13%)

Price & Performance

-5.52 (-18.82%) / 6M

$19.69$26.81$33.94$41.06Mar 30Jun 30Sep 29

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 43.6% away from all-time highs of $42.21
  • NAMS is down 32% since the beginning of the year
  • NAMS is down 16% over the past 12 months
  • NAMS is down 6% over the past 1 month
  • 21% of all NAMS investors are betting against NAMS

NAMS reads neutral: price sits above one of the two key moving averages, the 12-month move is -16.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.52
Earnings momentum -5.1% Quarterly EPS growth
Quarterly change -5.1%

Valuation

P/E ratio N/A
Enterprise value $2.3B
Beta 0.62

Balance sheet & scale

IncomeN/A
Revenue$7.1M
Cash$635.2M
Debt$82.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $2.8B

NewAmsterdam Pharma Co. NV is a clinical-stage biopharmaceutical company, which engages in the development of oral, non-statin medicine for patients at high risk of cardiovascular disease with residual elevation of low-density lipoprotein cholesterol. Its lead product candidate, Obicetrapib, is a next-generation, oral, low-dose cholesteryl ester transfer protein inhibitor, which will be used to prevent major adverse cardiovascular events. The company was founded on June 10, 2022 and is headquartered in Naarden, the Netherlands.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,184.63 -0.01%
JNJ Johnson & Johnson $267.57 -1.61%
ABBV AbbVie, Inc. $263.29 -1.12%
MRK Merck & Co., Inc. $149.28 +0.40%
RHHVF Roche Holding Ltd $431.56 -2.94%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.